36 related articles for article (PubMed ID: 34821101)
1. [Effects of ropivacaine hydrochloride on the proliferation, invasion and apoptosis of osteosarcoma cells and its mechanism].
Yu P; Yin TX; Luo CY; Zeng P
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):654-659. PubMed ID: 34821101
[No Abstract] [Full Text] [Related]
2. [Knockdown mitochondrial transcription factor A (TFAM) inhibits autophagy, proliferation, invasion and migration in human cervical cancer and osteosarcoma cells].
Xu Y; Gao L; Yang J; Wang J; Jiang X; Yu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Apr; 40(4):311-318. PubMed ID: 38710515
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells.
Wang X; Ding R; Fu Z; Yang M; Li D; Zhou Y; Qin C; Zhang W; Si L; Zhang J; Chai Y
Front Pharmacol; 2024; 15():1303732. PubMed ID: 38420199
[No Abstract] [Full Text] [Related]
4. Ropivacaine inhibits the proliferation and metastasis of gastric cancer cells via the SNX10/SRC/STAT3 pathway.
Deng RR; Yuan YP
Chem Biol Drug Des; 2024 Jan; 103(1):e14405. PubMed ID: 37989501
[TBL] [Abstract][Full Text] [Related]
5. Arctigenin Suppresses the Proliferation and Metastasis, and Induces Apoptosis and Cycle Arrest of Osteosarcoma Cells by inhibiting HMOX1 Expression.
Xu G; He Z; Liu Y
Anticancer Agents Med Chem; 2023; 23(20):2209-2216. PubMed ID: 37711016
[TBL] [Abstract][Full Text] [Related]
6. (E)-SIS3 suppressed osteosarcoma progression via promoting cell apoptosis, arresting cell cycle, and regulating the tumor immune microenvironment.
Huang Z; Zhang C; Zhu K; Hu J; Xu E; Ma X; Wang Y; Zhu Y; Zhu J
Drug Dev Res; 2023 Dec; 84(8):1751-1763. PubMed ID: 37784254
[TBL] [Abstract][Full Text] [Related]
7. Potential Anticancer Activity of Crude Ethanol, Ethyl Acetate, and Water Extracts of
Mpingirika EZ; El Hosseiny A; Bakheit SMS; Arafeh R; Amleh A
Biomed Res Int; 2020; 2020():3837693. PubMed ID: 32695811
[TBL] [Abstract][Full Text] [Related]
8. Tectorigenin inhibits osteosarcoma cell migration through downregulation of matrix metalloproteinases in vitro.
Guo Y; Chen YH; Cheng ZH; Ou-Yang HN; Luo C; Guo ZL
Anticancer Drugs; 2016 Jul; 27(6):540-6. PubMed ID: 26991068
[TBL] [Abstract][Full Text] [Related]
9. UBE2L3 Promotes Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression.
Zhao X; Shan G; Xing D; Gao H; Xiong Z; Hui W; Gong M
Recent Pat Anticancer Drug Discov; 2024 Feb; ():. PubMed ID: 38385491
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan Induces Osteosarcoma Cells Growth Inhibition and Apoptosis Via Suppressing mTOR Pathway.
Wang C; Wang WB
Open Life Sci; 2018 Jan; 13():242-249. PubMed ID: 33817089
[TBL] [Abstract][Full Text] [Related]
11. Proliferation, Apoptosis and Invasion effects of mistletoe alkali on human osteosarcoma U2OS in vitro.
Ge Y; Wang Y; Pang L; Zhang L; Zhai Y; Zhou H
Int Surg; 2016 Apr; ():. PubMed ID: 27110639
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles-encapsulated doxorubicin alleviates drug resistance of osteosarcoma via inducing ferroptosis.
Tian X; Zhang Y; Zhang M; Liu G; Hao Y; Liu W
Nanotoxicology; 2024 Jun; ():1-9. PubMed ID: 38907601
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin loaded octacalcium phosphate particles as controlled release drug delivery systems: Physico-chemical characterization, in vitro drug release and evaluation of cell death pathway.
Kovrlija I; Pańczyszyn E; Demir O; Laizane M; Corazzari M; Locs J; Loca D
Int J Pharm; 2024 Mar; 653():123932. PubMed ID: 38387818
[TBL] [Abstract][Full Text] [Related]
14. Azurin Regulates P21 and Enhances the Sensitivity of Osteosarcoma Cells to Cisplatin.
Chen Y; Zeng H; Hou M; Qiu Y
Altern Ther Health Med; 2023 Oct; 29(7):119-125. PubMed ID: 37442187
[TBL] [Abstract][Full Text] [Related]
15. MSX2 inhibits the growth and migration of osteosarcoma cells by repressing SOX2.
Wu Y; Jin Y; Yamamoto N; Takeuchi A; Miwa S; Tsuchiya H; Yang Z
Am J Transl Res; 2021; 13(6):5851-5865. PubMed ID: 34306330
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of calbindin 1, a calcium-binding protein, reduces the proliferation of osteosarcoma cells.
Huang Z; Fan G; Wang D
Oncol Lett; 2017 May; 13(5):3727-3733. PubMed ID: 28529588
[TBL] [Abstract][Full Text] [Related]
17. CeO
Tapeinos C; Battaglini M; Prato M; La Rosa G; Scarpellini A; Ciofani G
ACS Omega; 2018 Aug; 3(8):8952-8962. PubMed ID: 31459028
[TBL] [Abstract][Full Text] [Related]
18. PRKDC Induces Chemoresistance in Osteosarcoma by Recruiting GDE2 to Stabilize GNAS and Activate AKT.
Zhang W; Li W; Yin C; Feng C; Liu B; Xu H; Jin X; Tu C; Li Z
Cancer Res; 2024 Jun; ():. PubMed ID: 38900943
[TBL] [Abstract][Full Text] [Related]
19. Retraction notice to "Anti-proliferation and anti-metastatic effects of sevoflurane on human osteosarcoma U2OS and Saos-2 cells" [Experimental and Molecular Pathology 108 (2019) 121-130].
Gao K; Su Z; Liu H; Liu Y
Exp Mol Pathol; 2022 Aug; 127():104784. PubMed ID: 35797795
[No Abstract] [Full Text] [Related]
20. Retracted: Effect of Paclitaxel Combined with Doxorubicin Hydrochloride Liposome Injection in the Treatment of Osteosarcoma and MRI Changes before and after Treatment.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9816837. PubMed ID: 37501833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
